Sbir r44. These funds could be either federal or non-federal.
Sbir r44 Interested applicants are encouraged to review the list of NIOSH topics. GOV PHS 2024-02 OMNIBUS SOLICITATION OF THE NIH, CDC, AND FDA FOR SMALL BUSINESS INNOVATION RESEARCH GRANT APPLICATIONS (PARENT SBIR [R43/R44] CLINICAL TRIAL NOT ALLOWED) How to ApplyLearn how the program works, check if you meet eligibility requirements, and how to find additional local support and resources. Applicants are encouraged to contact NIH Scientific/Research staff for more detailed guidance. NIH Apr 1, 2025 · PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Apr 1, 2025 · PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Aug 12, 2024 · PA-24-246: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required). July 12, 2023 - PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed). NCI May 21, 2025 · This funding opportunity will solicit R43/R44 SBIR grant applications to provide support for the development of Technology-Enhanced Training Products for the health and safety training of workers exposed to hazardous materials. This FOA will utilize the SBIR (R43/R44) mechanisms, and runs in parallel to a FOA of similar scientific intent, PA-06-007, (Small Business Technology Transfer [STTR] Program Parent Announcement: Electronic Submission of Grant Applications through Grants. Otherwise, small businesses interested in the development of relevant innovative tools, technologies or products are encouraged to apply via the SBIR mechanism (R43/R44). Mar 11, 2025 · The NHGRI Small Business Program awards Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. Understand funding thresholds, impact scores, and how to increase your chances of securing non-dilutive funding. NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-19-018. NINDS Jun 2, 2022 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-22-177. NHGRI Oct 27, 2022 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) PAR-23-032. NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NIAID Advanced Technology SBIR (NIAID-AT-SBIR [R43/R44]) PA-10-123. NIEHS SBIR/STTR grants help small businesses develop innovative and commercially viable products or technologies to translate and communicate environmental health research to improve public health. NIH Jun 7, 2024 · Small Business Innovation Research (SBIR) Program Active R43/R44 funding opportunities A set-aside program designed to support innovative research that has the potential for commercialization of the subject research conducted by a small business concern. Small Business Concerns (SBCs) are encouraged to submit applications that further develop available technologies from the NIH Intramural Program and bring them to the commercial market. Phase I, which uses the R43 funding mechanism, offers up to $306,872 for a project timeline between 6 months to 2 years. gov) NIEHS will only support Phase I applications in response to this NOFO. Back to Funding Opportunities Search Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed) SBIR/STTR R43: <55 (experienced through PO and Institute interactions) SBIR/STTR R44: <55 (experienced through PO and Institute interactions) Recommend engaging with PO on any scored proposal. NCI Aug 5, 2024 · Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an interest in small business by simultaneously supporting their entrepreneurial development and the conduct of NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) PA-17-147. Applicant success rates of both the SBIR and STTR programs depend on the budget and the number of applications and can fluctuate from year to year. Jun 18, 2025 · NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Sample Funded Applications from NIAID Find under R41, R42, R43, and R44 – Small Business Sample Applications. SBA. Back to Funding Opportunities Search Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. B. I’ve also included links to “ cleared Apr 10, 2025 · PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Sep 15, 2022 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) RFA-NS-23-006. Jul 12, 2023 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-23-231. The first application due date is Tuesday, September 5, 2023, so start preparing your application today. NIGMS NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44) PA-12-196. com opportunity listing for the NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards federal grant. At the end of Phase II, small businesses are expected to fully commercialize their product or technology using non-SBIR funds. Below is a list of funding opportunity announcements that offer small business entrepreneurs a chance to obtain funding without requirements to give up equity or ownership for Apr 24, 2012 · If you win a SBIR Phase II grant to follow-up on Phase I and continue research for two more years, your first year of Phase II funding will be coded Type 2 R44. Most recent NIDDK funding announcements: R41/R42 and other Small Business awards The R41/42 at NIDDK The Small Business Innovation Research (SBIR) and the Small Business Technology Transfer (STTR) programs, also known as America's SEED Fund, are a key part of NIH's mission to turn discovery into health. This consists of classroom, online, and practical health and safety training technologies for workers and their supervisors, who are engaged in activities related to This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-06-129 that solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Mar 10, 2025 · PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) The SBIR Technology Transfer (SBIR-TT) Funding Opportunity Announcement (FOA) is intended to help move commercially-viable technologies from the NIH Intramural Program to the marketplace. e. Apr 1, 2025 · PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-24-245. Description The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, also known as America's Seed Fund, are one of the largest sources of early-stage capital for technology commercialization in the United States. gov Guide 13CFR121 defines what constitutes an employee and the SBA SBIR website provides answers to other common eligibility questions. NIEHS SBIR grants help small businesses develop innovative and commercially viable products or technologies for environmental health sciences. The statutory purpose of the SBIR program is to strengthen the role of innovative small NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Revolutionary Genome Sequencing Technologies – The $1000 Genome – SBIR (R43/R44) RFA-HG-06-004. Reviewers may access additional information on Phase II NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Studies (SBIR [R44]) PA-06-030. As usual, there are four Omnibus Solicitations: PA-23-230: PHS 2023-2 Omnibus Jul 24, 2018 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed) PA-18-871. Jun 26, 2024 · SBIR/STTR Application Basics For more information regarding Phase I Application support, visit NCI SBIR/STTR Training and Entrepreneurship Program Omnibus Solicitation and other grant opportunities follow the NIH Standard Receipt Dates for SBIR and STTR (September 5, January 5, April 5) SF424 SBIR/STTR Application Guide for NIH and Other PHS Agencies (Forms I) Annotated Form Set for NIH Small Topic Funding Opportunities Back to Funding Opportunities Search SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Back to Funding Opportunities Search NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) Renewal applications of SBIR Phase II awards (i. Dec 18, 2014 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: New Technologies for Viral Hepatitis SBIR (R43/R44) PA-15-077. Innovation and the potential for commercialization are two important aspects of the review criteria considered in the scientific and Aug 1, 2025 · Another option is the Fast-Track program, in which the small business submits applications for Phase I (either STTR R41 or SBIR R43) and Phase II (either STTR R42 or SBIR R44) in one initial application. NIH Mar 10, 2025 · PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) The SBIR Technology Transfer (SBIR-TT) Funding Opportunity Announcement (FOA) is intended to help move commercially-viable technologies from the NIH Intramural Program to the marketplace. No Yes Oct 27, 2015 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Novel Genomic Technology Development Direct to Phase II SBIR (R44) PAR-16-017. NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) PA-17-302. NIDA Oct 23, 2024 · July 03, 2024 - PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed). NIEHS The Key Dates section of many funding opportunities indicate standard dates apply. Jul 2, 2025 · PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-23-230) The Small Business Innovative Research (SBIR) and the Small Business Technology Transfer (STTR) Programs support research and development (R&D) of innovative technologies that have the potential to succeed commercially or to provide societal benefit. Objective: This solicitation requires that the SBIR applications propose at least one clinical trial. NIMH Jul 26, 2023 · July 12, 2023 – PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed). The NINDS Small Business Program has two main component programs: the Small Business Innovation Research (SBIR) Program and the Small Business Technology Transfer (STTR) Program. Do you meet the following thresholds? The primary employment of the PI is with the small business. NIMHD REMINDER: ALL APPLICATIONS MUST BE SUBMITTED IN RESPONSE TO A NOTICE OF FUNDING OPPORTUNITY THROUGH GRANTS. NHGRI Jul 12, 2023 · 7/12/23 The PHS 2023-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. Source: NIH Success Rate File SBIR/STTR - See SEED For additional information see web report # 215 Sep 17, 2025 · Activity Code: R43/R44 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Nov 6, 2024 · NIAMS participates in the NIH Parent Announcement for the SBIR/STTR program (the omnibus solicitation of SBIR/STTR grant applications -- parent SBIR/STTR clinical trial not allowed). NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2014-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) PA-14-071. SBIR Phase IIB) to conduct clinical trials are not included in this NOFO and should be submitted to NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional). Apr 16, 2025 · Phase 2 (R42/R44) continues research or research and development (R&D) efforts initiated in Phase 1. Evaluation is based on the results of Phase I, scientific and technical merit, and commercial potential and societal impact of the Phase II application. Nov 19, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-26-015. NCI Sep 28, 2023 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) RFA-DA-25-048. NINDS Jun 12, 2023 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-23-230. Use the table below and the activity code (e. NIAID NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the advanced stage development of pharmacological treatment agents for drug and nicotine abuse and dependence. A few additional notes: Mar 10, 2025 · PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Back to Funding Opportunities Search Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) Title: NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards Announcement Type This is a reissue of PA-03-154, which was previously released July 22, 2003. Jan 8, 2025 · Small Business The NEI Small Business Innovative Research (SBIR) (R43/R44) and Small Business Technology Transfer Research (STTR) (R41/R42) programs provide early-stage capital for innovative small U. NIH Dec 19, 2024 · The SBIR Program (R43 and R44 research grant mechanisms) supports research and development of aging- and health-focused products and services by small business concerns (SBCs) that may ultimately lead to commercialization. com opportunity listing for the Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) federal grant. Examples of Potential Tools, Technologies, or Products. Back to Funding Opportunities Search Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) Apr 1, 2025 · PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Jun 2, 2022 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-22-176. The SBIR/STTR program is a phased program. g. NIMH FederalGrants. NIH Sep 28, 2023 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) RFA-DA-25-048. Nov 17, 2025 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Notice of Early Expiration of NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Notices of Funding Opportunity and Guidance for Existing Recipients NOT-OD-26-006. Take time to learn about each step in the grants process from planning to apply through developing and submitting your application to award and post-award reporting. Sep 5, 2024 · The Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Omnibus Solicitations are intended to support small business innovation research across a broad spectrum of topic areas. NIA has an unprecedented R&D budget to develop interventions that prevent or treat Alzheimer’s disease (AD) and AD-related dementias. Note that competing renewal awards were formerly called competing continuation awards. NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the advanced stage development of pharmacological treatment agents for drug and nicotine abuse and dependence. Sep 24, 2024 · Learn about assistance programs, how to identify a potential funding organization, and past NIH funding. Small Business Innovation Research & Small Business Technology Transfer Grants (SBIR/STTR, R41, R42, R43, R44) (nih. Aug 7, 2024 · PHS 2024-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44], Clinical Trial Not Allowed) Back to Funding Opportunities Search NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Renewal applications of SBIR Phase II awards (i. Source: NIH Success Rate File SBIR/STTR - See SEED For additional information see web report # 215 On 3/8/24 National Institutes of Health issued SBIR / STTR Topic RFA-MD-24-006 for Innovations for Healthy Living- Improving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional) due 12/10/26 Nov 6, 2024 · NIAMS participates in the NIH Parent Announcement for the SBIR/STTR program (the omnibus solicitation of SBIR/STTR grant applications -- parent SBIR/STTR clinical trial not allowed). NIH July 12, 2023 - PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required). The main objective in SBIR/STTR Phase I is to establish the technical merit and feasibility of the proposed research and development efforts, whereas in SBIR/STTR Phase II it is to continue the R&D efforts to advance the technology toward ultimate commercialization. NHLBI Apr 23, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) RFA-CA-24-022. Please see filtered search results for NIAMS-related small business funding opportunities: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) NIMH will accept Phase IIb SBIR grant applications from Phase II SBIR awardees to continue the process of developing technologies that ultimately require federal regulatory approval. gov) that will utilize the R41/R42 grant mechanisms. NIGMS SBIR/STTR R43: <32 (experienced through PO and Institute SBIR (R43/R44) grants support domestic small businesses engaging in research and development that has the potential for commercialization. Apr 4, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-24-246. NIA Jun 15, 2023 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed) PAR-23-213. Renewal applications of SBIR Phase II awards (i. Renewal/resubmission/revision and AIDS-related applications may have different due NIH, under HHS, offers the largest share of SBIR/STTR funding for biomedical and health-related innovations. Jan 16, 2018 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-18-574. Jun 23, 2017 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Novel Assays for Screening the Effects of Chemical Toxicants on Cell Differentiation (SBIR R44) RFA-ES-17-007. NIH Jul 8, 2024 · PA-24-246: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required). You can also find information on the difference between SBIR and STTR application requirements. Budget amounts of $320k for Phase I and $2. NIH Nov 19, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-26-015. , R01) specified in the title of the opportunity to determine application cycles and their relationship to due dates, review and council dates, and earliest possible start dates. These funds could be either federal or non-federal. . The small business will do at least 67% of the research on this project. NIH Apr 4, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-24-245. NIH We would like to show you a description here but the site won’t allow us. NIAMS Nov 15, 2024 · NIH Paylines & Resources – Grant Q&A & advice I update this page as ICs revise their funding strategies and answer questions submitted as comments as I am able (usually within 1-5 days) – others monitoring the blog often chime in as well with their knowledge and experience, which is fabulous and will provide more value than I ever could on my own. May 28, 2025 · Gain insights into SBIR/STTR paylines by NIH Institute, including updated details on the NHLBI payline. FederalGrants. The SBIR funding (R43, R44) has additional eligibility restrictions. The statutory purpose of the SBIR program is to strengthen the role of innovative small business concerns (SBCs) in Federally-funded research or research and development (R/R&D). , SBIR Phase IIB) to conduct Phase I and II clinical studies should be submitted to NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44). Jan 22, 2025 · NIOSH co-sponsors grants for the Small Business Innovation Research (SBIR) program. Topic Funding Opportunities Back to Funding Opportunities Search NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Funding Agency HHS NIH Year: 2024 Topic Number: RFA-HL-26-015 Solicitation Number: RFA-HL-26-015 NIEHS SBIR grants help small businesses develop innovative and commercially viable products or technologies for environmental health sciences. We’ve recently updated our interim NIAID Paylines for research project grant (R), small business innovation research (SBIR), and small business technology transfer (STTR) awards. This FOA specifically invites The SBIR Phase II category is a sum of the Regular Phase II, Direct Phase II and Phase IIB sub-categories. NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) PAR-24-132. NHLBI Additional Instructions for SBIR/STTR: Additional SBIR/STTR instructions will be denoted by a gray call-out box with purple color coding and with the heading “Additional Instructions for SBIR/STTR” throughout these application instructions. Applications are accepted three times a year. companies for the purpose of engaging in federal Research & Development (R&D) that has a strong potential for commercialization. NIH Jun 21, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) PAR-24-222. Nov 18, 2024 · The NHLBI is interested in Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) activities that advance the prevention, diagnosis, and treatment of heart, lung, blood, and sleep disorders. NIH SBIR/STTR grant solicitation announcements and additional information are available on the NIH Small Business Funding Opportunities website. 5M for a Phase II (total costs, up to 3y). While universities can Mar 8, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) RFA-MD-24-006. NICHD Jun 21, 2022 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) PAS-22-196. Mar 22, 2023 · On March 22, 2023, NIAID updated the following Paylines and set their status to final: Small Business Technology Transfer (STTR) Phase I and II (R41, R42): 31 overall impact score Small Business Innovation Research (SBIR) Phase I and II (R43, R44): 34 overall impact score Institutional and Short-Term National Research Service Award (NRSA) Training (T32, T35): 18 overall impact score Career Phase II: Full Research/R&D Effort [type 2 R42 (STTR) and type 2 R44 (SBIR) applications] The objective of the Phase II is to continue the research or R&D efforts initiated in Phase I. Jan 22, 2025 · Phase II continues the R&D efforts to advance the technology toward ultimate commercialization. Includes information on eligibility, deadlines, requirements, and guidelines. NIH Apr 20, 2022 · Paylines—either percentiles (R01s only) or overall impact score order—are the funding cutoff points for investigator-initiated applications. S. SBIR helps businesses commercialize innovations from federal research. Small Business Innovation Research (SBIR) is defined by the following activity codes: R43, R44, SB1, U43 and U44. Nov 19, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-26-014. NIDDK May 21, 2019 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation (SBIR) (R44 Clinical Trial Not Allowed) RFA-GM-19-001. NIGMS Jun 18, 2025 · NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Each year, NIA provides nearly $150 million in R&D grants to small businesses through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. NIH rules for applying and accepting a grant. ydhwzuxpekahnebgfbzrlgnqpjabrgwsbdeymuupjeewajcnwrtwutbflcrmsbdtgkxxfdi